Structural changes in the capping groups of inverted cyanoacrylamide-based kinase inhibitors resulted in alterations in residence time, with some compounds exhibiting sustained pharmacological effects in vivo.
- J Michael Bradshaw
- Jesse M McFarland
- Jack Taunton